Implementation of lockdown across various countries because of pandemic has put an economic burden on the private healthcare sector. Medical service providers are facing shortage of raw materials required for the production of health supplements such as eye health supplements, across the globe. Various producers are facing issues such as shortage of labor and transportation of raw materials, which has impacted the production of the peripherally inserted central catheters. Most of the vehicles used for transportation of these products are stuck at the state borders or at the country’s borders. For instance, in July 2020, the Society for Vascular Surgery published a protocol for central venous access in patients with coronavirus (COVID-19), in the Elsevier, a Dutch publishing and analytics company which specializes in technical, scientific, and medical content.
Get Free PDF Sample Copy (Including Full TOC, List of Tables & Figures, Chart) @
https://www.coherentmarketinsights.com/insight/request-sample/4048
Similarly, on May 28, 2020, a group of experts from the Italian association GAVeCeLT (Gruppo Accessi Venosi Centrali a Lungo Termine) provided recommendations for using vascular access in COVID-19 patients. The recommendations encompass selection, insertion, and maintenance of venous access devices, developed to protect the operator and reduce the risk of infection. Following are the recommendations provided by the experts from GAVeCeLT for choosing the appropriate central venous catheters, insertion technique, and precautions to avoid operator contamination:
Application of a central venous access (peripherally inserted central catheters (PICC), femorally inserted central catheter (FICC), or centrally inserted central catheter (CICC) is recommended for COVID-19 patients in the Intensive Care Units (ICU)
Femoral access should be considered to prevent the risk of operator contamination by the patient’s oral, nasal, and tracheal secretions during insertion
Utilization of ultrasound guidance through wireless ultrasound probes for the insertion of any central venous access or midline catheter or peripheral arterial catheter is recommended in order to avoid risk of contamination
Adopt the standard barrier precautions such as skin antisepsis with 2% chlorhexidine in 70% isopropyl alcohol, non-sterile surgical mask, non-sterile cap, sterile gloves, waterproof sterile gown, and others for patient protection
Adopt the standard personal protective equipment (double glove, full suit, goggles or face shield, and footwear) for protection of the operator
Thus, impact of the coronavirus (COVID-19) pandemic is projected to restrict growth of the global peripherally inserted central catheters market over the forecast period.
Ask for PDF Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/4048
The growing number of product approvals from Egyptian regulatory bodies is projected to augment the growth of the global peripherally inserted central catheters market during the forecast period. For instance, in October 2018, Bactiguard received approval from the Egyptian Ministry of Health for BIP Foley, a urinary catheter.
The growing number of dialysis procedures performed in Africa is projected to drive the global peripherally inserted central catheters market growth over the forecast period. For instance, according to South African Renal Registry annual report 2016, around 3,175 patients were receiving dialysis treatment in the public sector in South Africa and 881 (27.8%) were undergoing peritoneal dialysis, in 2016.
The growing number of tenders for Bactiguards’s anti- infective central venous catheters (BIP CVC) products is driving global peripherally inserted central catheters market growth. For instance, in July 2018, Bactiguard won a Swedish tender, which covered the Skåne region. The tender enables hospitals in Skåne region to purchase Bactiguard’s anti-infective central venous catheters (BIP CVC) for at least two years, effective from October 2018 to October 2020.
Rise in prevalence of cancer in the U.S. is projected to drive the segment growth over the forecast period. For instance, according to the Cancer Atlas, by American Cancer Society, around 1.3 million new cases of cancer were diagnosed while around 666,000 cancer deaths occurred in Latin America and the Caribbean in 2018.
Reasons To buy The Peripherally Inserted Central Catheters Market Report:
➛ In-depth analysis of the market on the global and regional levels.
➛ Major changes in market dynamics and competitive landscape.
➛ Segmentation on the basis of type, application, geography, and others.
➛ Historical and future market research in terms of size, share growth, volume, and sales.
➛ Major changes and assessment in market dynamics and developments.
➛ Emerging key segments and regions
➛ Key business strategies by major market players and their key methods.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
https://www.coherentmarketinsights.com/promo/buynow/4048
Points cover in Global Peripherally Inserted Central Catheters Market Research Report:
Chapter 1: Overview of Global Peripherally Inserted Central Catheters Market (2022-2028)
- Definition
- Specifications
- Classification
- Applications
- Regions
Chapter 2: Market Competition by Players/Suppliers 2022 and 2028
- Manufacturing Cost Structure
- Manufacturing Process
- Industry Chain Structure
Chapter 3: Sales (Volume) and Revenue (Value) by Region (2022-2028)
- Sales
- Revenue and market share
Chapter 4, 5 and 6: Global Peripherally Inserted Central Catheters Market by Type, Application & Players/Suppliers Profiles (2022-2028)
- Market Share by Type & Application
- Growth Rate by Type & Application
- Drivers and Opportunities
- Company Basic Information
Chapter 7, 8 and 9: Global Peripherally Inserted Central Catheters Manufacturing Cost, Sourcing & Marketing Strategy Analysis
- Key Raw Materials Analysis
- Upstream Raw Materials Sourcing
- Marketing Channel
Chapter 10 and 11: Peripherally Inserted Central Catheters Market Effect Factors Analysis and Market Size (Value and Volume) Forecast (2022-2028)
- Technology Progress/Risk
- Sales Volume, Revenue Forecast (by Type, Application & Region)
Chapter 12, 13, 14 and 15: Global Peripherally Inserted Central Catheters Market Research Findings and Conclusion, appendix and data source
- Methodology/Research Approach
- Data Source (Secondary Sources & Primary Sources)
- Market Size Estimation
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837